Lidocaïne Hcl B. Braun

Lidocaine hydrochloride, the active ingredient in Lidocaïne Hcl B. Braun, is a local anesthetic (amide) presented as a sterile solution for intraosseous and intravenous use. It provides reversible nerve impulse blockade for minor surgical or diagnostic procedures and can be used intravenously to treat ventricular arrhythmias.

GNH USA supplies Lidocaïne Hcl B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidocaine hydrochloride is a local anesthetic that acts on peripheral nerves and cardiac tissue to block abnormal electrical activity. - Minor surgical procedures: provides rapid, reversible local anesthesia for incision and excision. - Diagnostic procedures: offers analgesia for endoscopic or catheter‑based examinations. - Ventricular arrhythmias: stabilises cardiac rhythm when administered intravenously in emergency settings.

Adverse reactions may vary with the route of administration and patient factors.

Common Side Effects: - Tingling or numbness at the injection site - Light‑headedness or dizziness - Nausea or vomiting - Metallic taste in the mouth - Local irritation or erythema - Transient visual disturbances

Serious or Rare Side Effects: - Seizures, especially with high plasma concentrations - Cardiac conduction abnormalities such as bradycardia or heart block - Severe allergic reactions including anaphylaxis - Methemoglobinemia leading to cyanosis - Respiratory depression or apnea in overdose situations

Lidocaine should be used with careful clinical assessment and monitoring. - Cardiac history: evaluate for pre‑existing conduction disorders before intravenous use. - Hepatic function: adjust dosing in patients with severe liver impairment. - Hypersensitivity: avoid in individuals with known allergy to amide‑type local anesthetics. - Elderly patients: start with lower doses and monitor for toxicity. - Prolonged infusion: consider serum level monitoring to prevent accumulation. - Store at room temperature: keep in original container, protect from moisture and light.

Lidocaine may interact with other drugs that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) – additive cardiac toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) – increase lidocaine plasma levels. - Amiodarone – potentiates lidocaine’s anti‑arrhythmic effect and risk of bradycardia.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide) – may enhance lidocaine‑induced hypotension. - Anticonvulsants (e.g., phenytoin) – alter lidocaine metabolism. - Other local anesthetics – risk of cumulative systemic toxicity.